These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 10380014

  • 1. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A, Tanaka-Taya K, Ueda S.
    Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
    [Abstract] [Full Text] [Related]

  • 2. Anti-P30-52 monoclonal antibody cross-reacted to Env V3 and inhibited the viral multiplication of HIV-1-infected MT-4 cells.
    Ota A, Bautista AN, Yadav ML, Ueda S.
    Hybridoma; 1999 Apr; 18(2):139-47. PubMed ID: 10380013
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cells.
    Ota A, Ueda S.
    Hybridoma; 1999 Jun; 18(3):235-41. PubMed ID: 10475237
    [Abstract] [Full Text] [Related]

  • 4. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the anti-HIV-1 activity of an anti-p17-derivative peptide (P30-52) monoclonal antibody.
    Ota A, Ueda S.
    Hybridoma; 1999 Aug; 18(4):305-14. PubMed ID: 10571260
    [Abstract] [Full Text] [Related]

  • 6. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
    Blomberg J, Lawoko A, Pipkorn R, Moyo S, Malmvall BE, Shao J, Dash R, Tswana S.
    AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
    [Abstract] [Full Text] [Related]

  • 7. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
    Ota A, Liu X, Fujio H, Sakato N, Ueda S.
    Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
    [Abstract] [Full Text] [Related]

  • 8. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
    Liu X, Ota A, Watanabe M, Ueda S, Saitoh A, Shinagawa H, Nakata A, Kurimura T, Wang X, Zhao Y.
    Microbiol Immunol; 1995 Feb; 39(10):775-85. PubMed ID: 8577268
    [Abstract] [Full Text] [Related]

  • 9. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J, Salvetti JL, Beltramini LM, Tonarelli G.
    Rev Argent Microbiol; 2004 Feb; 36(4):151-7. PubMed ID: 15786866
    [Abstract] [Full Text] [Related]

  • 10. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.
    Biochem J; 2006 Nov 01; 399(3):483-91. PubMed ID: 16827663
    [Abstract] [Full Text] [Related]

  • 11. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
    Shang F, Huang H, Revesz K, Chen HC, Herz R, Pinter A.
    J Virol; 1991 Sep 01; 65(9):4798-804. PubMed ID: 1714518
    [Abstract] [Full Text] [Related]

  • 12. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
    Liu F, Bergami PL, Duval M, Kuhrt D, Posner M, Cavacini L.
    AIDS Res Hum Retroviruses; 2003 Jul 01; 19(7):597-607. PubMed ID: 12908937
    [Abstract] [Full Text] [Related]

  • 13. Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120.
    Connelly RJ, Kahn M, Blake J, Haffar OK, Thomas EK.
    Virology; 1994 Dec 01; 205(2):554-7. PubMed ID: 7526543
    [Abstract] [Full Text] [Related]

  • 14. Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1.
    Niedrig M, Harthus HP, Bröker M, Meloen R, Gelderblom H, Pauli G.
    Hybridoma; 1993 Aug 01; 12(4):431-9. PubMed ID: 7503941
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.
    Pincus SH, Messer KG, Nara PL, Blattner WA, Colclough G, Reitz M.
    J Clin Invest; 1994 Jun 01; 93(6):2505-13. PubMed ID: 7515393
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP, Geyer SJ, Hanson CV, Hendry RM, Milman G.
    AIDS; 1994 Feb 01; 8(2):169-81. PubMed ID: 7519019
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.